Olverembatinib, an investigational multikinase inhibitor (approved in China for CML), inhibits Src-family kinases (e.g., Lyn, ...

The Hematology Society of Taiwan yesterday said acute myeloid leukemia (AML), a fast-growing cancer of the blood and bone marrow, can progress quickly and aggressively and urged the government to ...

The research on bone-marrow transplantation mirrors the arc of many medical advancements. I was one of the early ...

Enliven Therapeutics Inc. (NASDAQ:ELVN) is one of the 11 Stocks With 3x-5x Returns This Year. Enliven Therapeutics has seen ...

Latest stories by Dr Tulika Seth. Dr Tulika Seth writes for ETHealthworld.com and gives views & updates on the Indian Health industry.

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the National Medical Products Administration (NMPA) has accepted the ...

Brian Boyle 's fight against cancer continues to inspire people in all sorts of ways. Tony Capparelli, an artist from Oradell ...

Bioscience Co. Ltd.’s has announced IND acceptance by China’s National Medical Products Administration (NMPA) for the company’s LILRB4/CD3 T-cell engager bispecific antibody 6MW5311. The drug ...

A once-dismissed idea that a single pill could stop cancer now shapes how doctors treat the disease. This week, Oregon Health & Science University honored Dr. Brian Druker, the physician-scientist who ...

Another bidder, which remains unidentified, dropped out of the bidding process. Analysts at William Blair now think it ...

Regulatory filings show that Terns ultimately accepted an offer 15% lower than a previous proposal as four companies vied for ...

Take a first look at the American Society of Hematology HematOmics Program (ASHOP) platform & its promise to move ...